Skip to main content
Caplight Logo









3D Medicines Inc.

3D Medicines Inc.

Public

3D Medicines Inc. is now publicly traded

The data on this page reflects 3D Medicines Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Dec 15, 2022

Last Round

Private Placement

Jul 21, 2023

Total Funding Raised

$323.86M

Company Overview

3D Medicines Inc. operates in Healthcare and is based in Shanghai, Shanghai. Its recorded funding history includes an Early Funding round in October 2020.

3D Medicines Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative immuno-oncology drugs to manage cancer as a chronic disease.

Sector

Healthcare

AI Layer

Application

3D Medicines Inc. Comparables

Compare 3D Medicines Inc. with similar companies based on industry and business-model similarity.

3D Medicines Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genecast
74%
Beijing Geneplus Technology
69%
求臻医学
68%
Book a demo to see all comparables

For institutional investors. Book with your work email.

3D Medicines Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJul 21, 2023
IPODec 15, 2022
Early FundingOct 8, 2020
Early FundingNov 23, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

John Z. Gong

Chairman And CEO

Executive Team

张竞

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

3D Medicines Inc. Investors

Notable investors and investment history

3D Medicines Inc. investors
InvestorRounds
Hyde Investment Holding GroupEarly Funding
China Securities (International) Corporate Finance Company LimitedIPO
China International Capital Corporation Hong Kong Securities LimitedIPO
Southwest Securities (HK) Brokerage LimitedIPO
Efung CapitalIPO, Early Funding
China Equity GroupEarly Funding
Ruiyi InvestmentEarly Funding

3D Medicines Inc. Filings

Explore SEC and related filing metadata, where available.

3D Medicines Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

HeadquartersShanghai, Shanghai
Employee Range108
Year Founded2014
Last FundingJul 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?